Interpretation of the clinical practice guidelines for Ketamine in total joint arthroplasty in 2022
10.3760/cma.j.cn115396-20230923-00073
- VernacularTitle:2022年《氯胺酮在全关节置换术中的应用》的临床实践指南解读
- Author:
Fan WANG
1
;
Huanhuan XU
;
Rui MA
;
Yujie MA
;
Xianjie WAN
;
Ke XU
;
Peng XU
Author Information
1. 延安大学医学院，延安 716000
- Keywords:
Arthroplasty, replacement;
Ketamine;
Guidebookes;
Medical guidelines
- From:
International Journal of Surgery
2024;51(3):203-206
- CountryChina
- Language:Chinese
-
Abstract:
The American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons, and the American Society of Regional Anesthesia and Pain Medicine collaborated to develop an evidence-based study about the safe and effective use of Ketamine in total joint arthroplasty(TJA). Based on the systematic review and Meta-analysis of several studies, the following conclusions are drawn: Ketamine can effectively relieve the postoperative pain of patients; Ketamine can effectively reduce the occurrence of postoperative nausea and vomiting; Ketamine can reduce the use of postoperative opioids; intraoperative use of Ketamine does not increase the incidence of postoperative adverse reactions. The above conclusions are graded according to the strength of evidence support. This article interprets the guidelines to provide reference for addressing the effectiveness and safety of Ketamine use in TJA.
